Big pharma, Insight journal - Dealtalk

M&A trends: Warner Chilcott Said to Consider Options After Interest

Posted on 01 May 2012

Tags: , , ,

Warner Chilcott is weighing options including a possible M&A after receiving interest from strategic and private-equity buyers, according to people with knowledge of the matter. The shares jumped in early trading.

Goldman Sachs Group is helping the drugmaker assess interest, said the people, who declined to be identified because the discussions are private. Warner Chilcott is also considering paying a dividend as an alternative to a sale, one person said.

Warner Chilcott climbed 18 percent to $22.10 at 8:17 a.m. On April 27, the stock rose 8 percent on takeover speculation by investors, giving the company a market capitalization of $4.69 billion. The Dublin-based drugmaker focuses on women’s health care, dermatology, urology and gastroenterology. It has an enterprise value, a figure that includes net debt, of $7.93 billion, according to data compiled by Bloomberg.

Read the full article at Bloomberg (link no longer available)

 

Related

Read: more on M&A deals in pharma, biotech, life science partnering deal news, insights and glossary

Read: Big pharma deal news- latest deal news for top 50 pharma / big pharma companies

Report: Merger and Acquisition Terms and Agreements

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply